Earnings

LifeMD Lowers FY2026 Sales Guidance from $220.000M-$230.000M to $205.500M-$212.500M vs $222.046M Est

Aug 5, 2026 · 04:49 PM ET· updated 2h ago

LifeMD (NASDAQ:LFMD) lowers FY2026 sales outlook from $220.000 million-$230.000 million to $205.500 million-$212.500 million vs $222.046 million estimate.

Why It Matters

LifeMD said it expects to make less money next year than it thought before—about $10 million less. This tells investors the company is being more careful about how fast it can grow.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

LFMD3.28

-0.63 (-16.03%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.